Monoclonal Antibody for RSV Prevention (Nirsevimab)
Protect infants from RSV infection and reduce the severity of symptoms with Nirsevimab, a monoclonal antibody for RSV prevention. This immunization provides ready-made RSV-specific antibodies, enabling the body to fight the virus immediately and safely.
Effectiveness of Monoclonal Antibody for RSV Prevention (Nirsevimab) in Infants:
- Reduces the risk of RSV infection by up to 79.5%
- Lowers the risk of hospitalization due to lower respiratory tract infection from RSV by up to 82.7%
- Decreases ICU ventilator use by 75.3%
- Provides protection for up to 6 months, covering the peak RSV season
| Program | Promotion Price (THB) |
| Monoclonal Antibody for RSV Prevention (Nirsevimab) – 1 Dose (50 mg) (for newborn aged 0-1 month and weight under 5 kg) |
11,900 |
Monoclonal Antibody for RSV Prevention (Nirsevimab) – 1 Dose (50 mg) Special price
|
9,900 |
| Monoclonal Antibody for RSV Prevention (Nirsevimab) – 1 Dose (100 mg) (for infants aged over 1 month -12 months and weigh over 5 kg) |
15,000 |
| Monoclonal Antibody for RSV Prevention (Nirsevimab) – 2 Doses (200 mg) for children aged 12–24 months |
29,500 |
Since RSV typically spreads during the rainy season, monoclonal antibody injections provide immediate protection and can prevent RSV infection for up to 5 months.
Terms and Conditions
- Prices do not include doctor’s fees or hospital service fees
- Available only to Thai nationals and foreigners residing in Thailand
- Available for purchase through May 31, 2026; privilege valid until June 30, 2026
Contraindications for Monoclonal Antibody for RSV Prevention (Nirsevimab)
Do not administer the monoclonal antibody for RSV prevention to children with a history of severe allergic reactions to Nirsevimab or its components, such as arginine or histidine.
Additional Notes:
- Monoclonal antibody for RSV prevention is important for building immunity in infants during their first year of life
- Infants aged 0–2 years with underlying health conditions are eligible to receive the injection
- It can be administered alongside routine childhood vaccines without the need to space them out—even with live vaccines, as it does not interfere with vaccine-induced immunity.
- Monoclonal antibody for RSV prevention can be given at the same time as other vaccines, as long as each is injected at a different site.